首页> 外国专利> Derivatized DTPA Complex, Pharmaceutical Formulations Containing the Compound, Uses thereof, and Methods of Making the Same.

Derivatized DTPA Complex, Pharmaceutical Formulations Containing the Compound, Uses thereof, and Methods of Making the Same.

机译:衍生的DTPA配合物,含有该化合物的药物制剂,其用途及其制备方法。

摘要

Compounds of the general formula IMAGE in which Z1 and Z2 each represent a hydrogen atom or the radical -(CH2)m-(C6H4)q-(O)k-(CH2)n(C6H4) l-(O)r-R, in which m and n denote the figures 0 - 20, k, l, q and r denote the figures 0 and 1 and R denotes a hydrogen atom, an unsubstituted or OR1-substituted C1-C6-alkyl radical or a CH2COOR1 group where R1 denotes a hydrogen atom, a C1-C6-alkyl radical or a benzyl group, X represents a hydrogen atom and/or a metal ion equivalent of an element of atomic number 21 - 29, 42, 44 or 57 - 83, with the proviso that at least two of the substituents X represent a metal ion equivalent in which one of the substituents Z1 and Z2 represents a hydrogen atom and the other does not represent a hydrogen atom, in which - if n and l each represent the figure 0 - k and r do not simultaneously each denote the figure 1, in which Z1 or Z2 do not represent -CH2-C6H4-O-CH2-COOCH2C6H5 or CH2-C6H4-O-(CH2)5-COOCH2C6H5 and in which -(O)r-R does not represent -OH, and their salts with inorganic and/or organic bases, amino acids or amino acid amides, are useful pharmaceutical agents.
机译:通式的化合物,其中Z 1和Z 2分别代表氢原子或-(CH2)m-(C6H4)q-(O)k-(CH2)n(C6H4) 1-(O)rR,其中m和n表示图0-20,k,l,q和r表示图0和1,R表示氢原子,未取代或OR 1-取代的C1- C 6烷基或CH 2 COOR 1基,其中R 1表示氢原子,C 1 -C 6烷基或苄基,X表示氢原子和/或原子元素的金属离子当量编号21-29、42、44或57-83,条件是至少两个取代基X代表金属离子当量,其中取代基Z 1和Z 2之一代表氢原子,且其他不代表氢原子,其中-如果n和l分别代表图形0-k和r不同时代表图形1,其中Z 1或Z 2不代表-CH 2- C6H4-O-CH2-COOCH2C6H5或CH2-C6H4-O-(CH2)5-COOCH2C6H5,其中-(O)rR它们不代表-OH,并且它们与无机和/或有机碱,氨基酸或氨基酸酰胺的盐是有用的药剂。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号